Navigation Links
Lilly Reports Third-Quarter 2011 Results
Date:10/20/2011

e mid-single digits. The company still anticipates that the impact of U.S. health care reform will lower 2011 revenue by $400 million to $500 million. 2011 revenue guidance assumes rapid and severe erosion of global Zyprexa sales after patent expirations in major markets, including the U.S. starting in October 2011, and the continued erosion of U.S. Gemzar sales. The company expects these reductions in revenue to be offset by sales growth of Alimta, Cialis, Cymbalta, Effient, Humalog and animal health products.

The company still anticipates that gross margin as a percent of revenue will decline between 2 and 3 percentage points.

Marketing, selling and administrative expenses are still projected to grow in the high-single digits and still include an estimated $150 million to $200 million in non-tax deductible expense for the mandatory pharmaceutical manufacturers fee associated with U.S. health care reform. Research and development expense growth is still projected to be in the low single digits.

Other income is now expected to be a net expense of between $175 million and $225 million.

The tax rate is now expected to be approximately 20 percent on a non-GAAP basis and approximately 19.5 percent on a reported basis.

Cash flows are still expected to be sufficient to fund capital expenditures that are now expected to be approximately $700 million, as well as anticipated business development activity and the company's dividend.

Webcast of Conference Call

As previously announced, investors and the general public can access a live webcast of the third-quarter 2011 financial results conference call through a link on Lilly's website at www.investor.lilly.com. The conference call will be held today from 9:00 a.m. to 10:00 a.m. Eastern Daylight Time (EDT) and will be available for replay via the website through November 18, 2011.

Lilly, a leading innovation-driven corporation, is devel
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Lilly Declares Fourth-Quarter 2011 Dividend
2. Lilly Announces Changes in Senior Management
3. Lilly Confirms Date and Conference Call for Third-Quarter 2011 Financial Results Announcement
4. Lilly Improves Its Environmental Footprint in Business Operations and Helps Beautify Communities
5. Eli Lilly and Company Bringing Diabetes Education Program to the Annual Legislative Conference
6. Lilly Celebrates 17th Consecutive Year as One of Working Mother 100 Best Companies
7. Lilly Health Channel Debuts on YouTube
8. Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
9. The American Diabetes Association and Eli Lilly and Company Encourage African Americans to Learn About Diabetes Through a Familiar Face
10. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
11. U.S. Court of Appeals Affirms Validity of Lillys Strattera Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... marzo 2015  SI-BONE, Inc., una società per ... fusione con chirurgia mininvasiva (minimally invasive surgical/MIS) per ... System ® , ha annunciato oggi che oltre ... intero utilizzando oltre 44.000 iFuse Implants.  ... adottata guadagnando consenso con oltre 900 chirurghi che ...
(Date:3/2/2015)... March 2, 2015 Isis Pharmaceuticals, Inc. (NASDAQ: ... $15 million milestone payment from GSK related to advancing the ... familial amyloid polyneuropathy (FAP).  "We are very ... , and plan to report data from the Phase 2/3 ... fifteen months of dosing and are now receiving ISIS-TTR Rx ...
(Date:3/2/2015)... 2, 2015   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... developing breakthrough treatments for human disease, will release its ... Wednesday, March 4, 2015 before the financial markets open.  ... to discuss clinical development progress and financial results for ... 10:00 a.m. Eastern Time on March 4, 2015. ...
Breaking Medicine Technology:SI-BONE, Inc. rivela l'obiettivo di 15.000 interventi con iFuse 2SI-BONE, Inc. rivela l'obiettivo di 15.000 interventi con iFuse 3SI-BONE, Inc. rivela l'obiettivo di 15.000 interventi con iFuse 4Isis Pharmaceuticals Earns $15 Million From GSK for Advancing ISIS-TTR Rx 2Isis Pharmaceuticals Earns $15 Million From GSK for Advancing ISIS-TTR Rx 3Lexicon To Report Fourth Quarter And Year End 2014 Financial Results On March 4, 2015 2
... 13 Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) ... Annual Healthcare Conference on Friday, September 17, 2010 at 8:35 ... at the Four Seasons in Boston.  Steve Worland, Ph.D., President ... of Anadys and its clinical development programs. Dr. ...
... Amgen (Nasdaq: AMGN ) will participate in ... the St. Regis New York in New York City, beginning ... president of Global Development, for Amgen, will present at the ... the Internet and can be accessed from Amgen,s website, ...
Cached Medicine Technology:Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences 2
(Date:3/2/2015)... ProvidaStaff has announced today that ... division to EDU Healthcare to reflect better ... systems and students nationwide. , “ProvidaStaff has always been ... the country,” said Angela M. Lewis, President of ProvidaStaff. ... and the introduction of EDU Healthcare better aligns our ...
(Date:3/1/2015)... 2015 To help healthcare ... their practices compliantly and profitably, MDreferralPRO and ... The interoperability between a strategic referral ... practice management system is necessary for a ... A referral management and development solution relies ...
(Date:3/1/2015)... Metamora, Michigan (PRWEB) March 01, 2015 ... approved to treat Overactive Bladder (OAB) symptoms, such as a ... adults when another type of medication (anticholinergic) does not work ... different treatment option that takes another approach to targeting the ... BOTOX® works on the nerves and bladder muscle, blocking the ...
(Date:3/1/2015)... March 01, 2015 A federal ... http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) scheduled to go to trial in ... a witness to provide testimony regarding the role ... of the Profemur device, Bernstein Liebhard LLP comments. ... Court, Northern District of Iowa on February 25th, ...
(Date:3/1/2015)... ERISAPros is pleased to announce the ... professional staff of its Compliance Department. , Evelyn King, ... University-Mortiz College of Law. Prior to joining ERISAPros, Evelyn ... Fortune 500 companies as well as several privately held ... experiences range from benefit plan design, vendor management, administrative ...
Breaking Medicine News(10 mins):Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 2Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 2Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 4Health News:Women's Excellence Now Offers BOTOX For Overactive Bladder Treatment 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3Health News:ERISAPros Recruits Evelyn King, J.D. and Carolyn Roddy, J.D. to its Professional Staff 2
... IT Company Launches into EXACENT,s Virtualized Environment , ... ... grade - on demand virtual data center , is pleased ... , ,HybridChart, a Scottsdale based company, has developed innovative and user-friendly ...
... suggests it might be possible , , THURSDAY, Feb. 19 ... hearing loss in lab animals, a new study shows. ... may be possible to create a pill that protects ... , Two studies found that giving supplements containing antioxidants ...
... Healthcare has always been a vital issue for Americans ... industry -- financial wellness. The two are far more closely ... and AOL Health found that debt stress is a major ... likely to have health problems, 20% more likely to have ...
... for Natural Dentistry - San Diego County,s premiere dental ... revolutionary care program designed to promote whole-body health at ... 19 Most people despise the dentist - the ... lights. It causes many Americans to skip the dentist ...
... experimental therapy using tiny bubbles activated by transcranial ... drug tissue plasminogen activator (tPA) is more effective ... ischemic stroke, according to new research presented at ... San Diego. , The findings, presented by Andrei ...
... Systems and, Romer Labs for use ... Pro analytical software,SUNNYVALE, CA, Feb. 19 /PRNewswire-FirstCall/ - MDS ... discovery and life sciences research, today announced that two ... Beacon Analytical Systems, which focuses on the development and ...
Cached Medicine News:Health News:EXACENT To Provide IT VIirtualization To HybridChart 2Health News:EXACENT To Provide IT VIirtualization To HybridChart 3Health News:A Pill to Prevent Hearing Loss? 2Health News:Recession Spawns Vital New Industry - Financial Wellness 2Health News:Recession Spawns Vital New Industry - Financial Wellness 3Health News:Discover Whole Body Wellness Through a Revolutionary - and Natural - Approach to Dental Care 2Health News:Discover Whole Body Wellness Through a Revolutionary - and Natural - Approach to Dental Care 3Health News:Study shows ultrasound and tPA effective for stroke 2Health News:MDS Analytical Technologies Announces Validation of Two More Kits for High-Throughput Detection of Melamine in Food 2Health News:MDS Analytical Technologies Announces Validation of Two More Kits for High-Throughput Detection of Melamine in Food 3Health News:MDS Analytical Technologies Announces Validation of Two More Kits for High-Throughput Detection of Melamine in Food 4
... nebulizer system offers an affordable and ... COPD or other respiratory conditions. The ... gives patients the ability to take ... Its unique nebulizer design delivers powerful ...
... The most compact, portable DC powered ... Elite provides the freedom to take ... system is powered by the included ... Adapter and Battery Kit. The integral ...
... The 50 psi MaxiCompressor, the ... to run 24 hours a ... It features a tamper-proof locking ... unintentional increases or decreases in ...
... PulmoStar is a low cost compressor/nebuliser which offers ... the home, health centre or clinic. The SunMist ... and a simple filter change every six months., ... With Disposable Neb, 3 Prong Polarized plug With ...
Medicine Products: